Friday, February 24, 2012

Nature Reviews Cancer contents March 2012 Volume 12 Number 3 pp 151-226

Nature Reviews Cancer

Advertisement
Pre-cloned promoter and 3'UTR reporter assays

The LightSwitch Luciferase Assay System provides everything you need for reporter assays: pre-cloned human promoters and 3'UTRs in luciferase reporter vectors plus optimized luciferase reagents to measure promoter induction and miRNA target validation. Visit SwitchGear Genomics and explore our genome-wide collections and validated pathway sets.
 
TABLE OF CONTENTS
 
March 2012 Volume 12 Number 3Advertisement

Nature Reviews Cancer cover
Impact Factor 37.178 *
In this issue
Research Highlights
Reviews
Perspectives

Also this month
Article series:
Genomic instability in cancer
 Featured article:
The insulin and insulin-like growth factor receptor family in neoplasia: an update
Michael Pollak



Apoptosis Detection: A streamlined approach.
New BD FACSuite™ software on the BD FACSVerse™ flow cytometry system provides predefined research assays matched with reagent kits, making it easy to achieve reproducible, consistent results. Download a free application note on apoptosis detection and see the exciting innovations behind the new BD FACSVerse.
bdbiosciences.com/go/verse


Subscribe
 
Facebook
 
RSS
 
Recommend to library
 
Twitter
 
Advertisement
High-quality Gene Expression & miRNA Results from FFPE Samples

Leading cancer researchers worldwide are utilizing NanoString's nCounter® Analysis System to explore the
frontiers of cancer biology. The system enables very
precise, digital quantification of up to 800 nucleic acid
targets per reaction and is compatible with FFPE samples
up to 20 years old. Click to learn more.
 
RESEARCH HIGHLIGHTS

Top

Metastasis: Navigating uncharted territory
p151 | doi:10.1038/nrc3229
Two papers published in Cell expand our knowledge and raise new questions about how metastasis occurs in pancreatic cancer.

PDF


Genomic instability: Shattered details
p152 | doi:10.1038/nrc3228
Two new studies provide mechanistic insights into the phenomenon of chromothripsis in cancer.

PDF


Microenvironment: Enforced compliance
p152 | doi:10.1038/nrc3240
In order to proliferate, cells with oncogenic mutations might first need to escape the restrictions of the epithelial environment.

PDF


Leukaemia: Targeting menin
p154 | doi:10.1038/nrc3231
Inhibitors that target the interaction between menin and MLL could be useful for the treatment of acute lymphocytic leukaemia.

PDF


Angiogenesis: Scheduled delivery
p154 | doi:10.1038/nrc3232
Data from patients with non-small-cell lung cancer (NSCLC) indicate that angiogenesis inhibitors may not increase the delivery of chemotherapy.

PDF


Morphology: Oncogenic morphs of p53
p155 | doi:10.1038/nrc3230
Prives and colleagues show that two p53 mutants exhibit oncogenic functions such that they increase the expression of the mevalonate pathway, which causes altered morphology of mammary acini.

PDF


Epigenetics: Histone modification at the gene level
p156 | doi:10.1038/nrc3233
Two new studies identify mutations in histone variants in high-grade paediatric gliomas

PDF


Metastasis: Leaky effect
p157 | doi:10.1038/nrc3227
Data that support a link between pericyte loss and metastasis have been published in Cancer Cell.

PDF



IN BRIEF

Metabolism: Context-specific metabolism | Alternative splicing: Dose-dependent splicing | Hypoxia: Scaffolding the regulation of hypoxia | Therapeutics: Passed down to the next generation | Tumour heterogeneity: All mixed up | Therapeutic resistance: Rational combination
PDF

Cancer
JOBS of the week
postdoc fellow or junior faculty position
Ohio State University Medical Center
Postdoctoral Fellow in Cancer Research
European Bioinformatics Institute (EBI)
Postdoctoral Fellow in Immunology
Univ of Texas M. D. Anderson Cancer Center
Post-Doctoral (WW) - Target Identification and Drug Discovery - Immunobiology and Cancer Research Program (W Wang)
Oklahoma Medical Research Foundation (OMRF)
Postdoctoral Fellow
Mount Sinai School of Medicine
More Science jobs from
Cancer
EVENT
Stromal-epithelial interactions in breast cancer development and progression
15.-18.04.12
Manchester, UK
More science events from
Advertisement
Rapid somatic mutation analysis powered by Assays by Sequenom

• Rapidly validate or profile somatic mutations in tumor samples
• Select from our research use OncoCarta™ family of 600 assays
• Or send us your list by gene, pathway, or tissue
• Let us design the assays and run your samples
• No instrumentation or system required

 
REVIEWS

Top
The insulin and insulin-like growth factor receptor family in neoplasia: an update
Michael Pollak
p159 | doi:10.1038/nrc3215
This Review reflects on the recent disappointing initial results from Phase III trials of insulin-like growth factor I receptor (IGF1R)-specific antibodies for cancer treatment, and discusses the next steps in targeting insulin and IGFI signalling in cancer therapy.
Abstract | Full Text | PDF


Epithelial stem cells, wound healing and cancer
Esther N. Arwert, Esther Hoste & Fiona M. Watt
p170 | doi:10.1038/nrc3217
There are many connections between wound healing and tumorigenesis. Using the epidermis as an example, this Review discusses these connections and how stem cells affect these two processes.
Abstract | Full Text | PDF


The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention
Jeffrey M. Peters, Yatrik M. Shah & Frank J. Gonzalez
p181 | doi:10.1038/nrc3214
Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors that are involved in regulating glucose and lipid homeostasis, inflammation, proliferation and differentiation. This Review discusses the roles of PPARs in cancer and focuses on PPARβ/δ and the controversies yet to be resolved.
Abstract | Full Text | PDF


The nuclear envelope environment and its cancer connections
Kin-Hoe Chow, Rachel E. Factor & Katharine S. Ullman
p196 | doi:10.1038/nrc3219
Aberrant nuclear morphology is already used as a diagnostic criterion for cancer, but why is the nucleus deformed in cancer cells? This Review discusses how components of the nuclear envelope and the adjoining lamina are deregulated in cancer cells and the consequences of this change in cell morphology.
Abstract | Full Text | PDF


Advertisement
Accurately measure subcutaneous tumors
The TumorImager™ rapidly scans subcutaneous tumors (~1 sec) without requiring anesthesia, providing highly sensitive, reproducible measurements of drug response in your preclinical oncology studies. TumorManagerTM can handle all aspects of your animal studies from protocol design to analysis. For a free web demo:
http://www.biopticon.com/tumorImager.php

 
PERSPECTIVES

Top
OPINION
Lymphatic and interstitial flow in the tumour microenvironment: linking mechanobiology with immunity
Melody A. Swartz & Amanda W. Lund
p210 | doi:10.1038/nrc3186
Tumours often engage the lymphatic system to invade and metastasize. This Opinion article proposes that increased interstitial and lymphatic flow in the tumour microenvironment, and the resulting mechanical changes to the tumour stroma, may strongly alter host immunity to the tumour.
Abstract | Full Text | PDF


OPINION
Article series: Genomic instability in cancer
RB: mitotic implications of a tumour suppressor
Amity L. Manning & Nicholas J. Dyson
p220 | doi:10.1038/nrc3216
The RB family is usually associated with the regulation of the G1/S transition and cell cycle entry. Recent data have shown a role for the RB family in regulating S phase and mitosis, which has implications for the genomic stability of tumour cells in which the RB family is inactivated.
Abstract | Full Text | PDF


Advertisement
90 page eBook --- download now for free!
Published in January 2012

Key Advances in Medicine summarizes the key clinical studies published in 2011 and highlights the trends to watch for in 2012. The perfect resource for busy medical students, physicians, and clinical researchers who want to catch up with the medical literature from 2011. Don't miss out!

 
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events
*2010 Journal Citation Report (Thomson Reuters, 2011)

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/myaccount
(You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department

For print subscription enquiries, please contact our subscription department

For other enquiries, please contact our feedback department

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group

No comments: